(secondQuint)An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier Gastrointestinal Liner System.

 This is an open-label extension study for subjects who participated in the control arm of study #09-1 (A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier Gastrointestinal Liner System vs.

 Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents) who are not treatment failures and completed 12 months of the study.

.

 An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier Gastrointestinal Liner System@highlight

A multi-center, single-arm, open-label study to evaluate the safety and effectiveness of the EndoBarrier Gastrointestinal Liner System liner on glycemic control in control subjects from study #09-1 who are not treatment failures and have completed 12 months of the study.

